Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) closed at $2.99 up 1.70% from its previous closing price of $2.94. In other words, the price has increased by $1.70 from its previous closing price. On the day, 1.12 million shares were traded. ZNTL stock price reached its highest trading level at $3.1 during the session, while it also had its lowest trading level at $2.92.
Ratios:
For a deeper understanding of Zentalis Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.59 and its Current Ratio is at 6.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 04 ’24 when Vultaggio Vincent sold 1,603 shares for $3.18 per share. The transaction valued at 5,098 led to the insider holds 33,855 shares of the business.
Gallagher Cam sold 9,597 shares of ZNTL for $114,972 on May 31 ’24. The President, Interim CFO now owns 633,680 shares after completing the transaction at $11.98 per share. On May 09 ’24, another insider, HAUSMAN DIANA, who serves as the Chief Medical Officer of the company, sold 3,356 shares for $12.62 each. As a result, the insider received 42,353 and left with 373,876 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 212612928 and an Enterprise Value of -169745184. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.24 while its Price-to-Book (P/B) ratio in mrq is 0.56. Its current Enterprise Value per Revenue stands at -4.185 whereas that against EBITDA is 0.774.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $21.34, while it has fallen to a 52-week low of $2.83. The 50-Day Moving Average of the stock is -11.11%, while the 200-Day Moving Average is calculated to be -67.67%.
Shares Statistics:
For the past three months, ZNTL has traded an average of 1.77M shares per day and 1171260 over the past ten days. A total of 70.77M shares are outstanding, with a floating share count of 61.39M. Insiders hold about 13.67% of the company’s shares, while institutions hold 100.06% stake in the company. Shares short for ZNTL as of 1727654400 were 8636183 with a Short Ratio of 4.89, compared to 1724976000 on 12281137. Therefore, it implies a Short% of Shares Outstanding of 8636183 and a Short% of Float of 24.51.
